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Studies on the renin-aldosterone system in the acute nephritic
syndrome. This study was undertaken to analyze the renin-al-
dosterone system in patients with acute nephritic syndrome
(ANS). Thirteen patients with ANS and mild to moderately se-
vere hypertension were studied on their hospital admission when
they were without medications (period A) and again, after recov-
ery, when they were on a sodium-restricted diet (period B). Their
data was compared with that of control children on diets with 10
mEq of sodium per day (10 subjects), 150 mEq of sodium per day
(18 subjects), and 300 mEq of sodium per day (10 subjects). The
following results were obtained (means SEM): (I) Plasma renin
activity (PRA) (nglmi/hr) in period A (1.13 0.97) was sup-
pressed (P < 0.001) compared with period B (5.45 0.83), and it
was comparable to the values in sodium-loaded children (1.91
0.27). (2) Plasma aldosterone (PAid0) (pg/mi) followed the same
pattern (period A, 81.6 23.3; period B, 289.3 52.1; controls
on 300 mEq of sodium per day, 68.8 9.6), as did urinary al-
dosterone (UAIdO) (pg/day) (period A, 4.07 1.01; period B,
30.16 7.06; controls on 150 mEq of sodium per day, 27.87
7.01). (3) There were no differences in period B and controls in
sodium restriction (4) No differences were detected in aldoste-
rone clearance, plasma ACTH, or serum and urinary potassium
in the patients and control children. (5) Correlations existed be-
tween PRA and PAIdO (r = 0.78, P < 0.001) or UAIdO (r 0.82, P <
0.001) and were similar in controls. (6) The severity of hyper-
tension correlated with fluid retention (r = 0.741, P < 0.001); (7)
The fluid retention correlated with the suppression of PRA (ex-
pressed as percent of period B values) in a relationship suggest-
ing that 80% suppression was rapidly achieved with a 5 to 6%
weight gain. We conclude that, in our patients, the renin-aldoste-
rone system appeared to function physiologically. The degree of
suppression and the internal relationship were comparable to the
normal response.
Etude du système rénine-aldostérone dans le syndrome néphri-
tique aigu. Cette étude a été entreprise pour analyser Ic système
rénine-aldostérone dans le syndrome néphritique aigu (ANS).
Treize malades atteint d'ANS et dont l'hypertension artérielle
était modérée ou moyennement sévère ont été étudiés a
l'admission (période A) puis, après amelioration, au cours d'une
restriction en sodium (période B). Les résultats obtenus ont été
compares a ceux d'enfants servant de contrôles recevant 10
mEq de sodium par jour (10 sujets), 150 mEq de sodium par jour
(18 sujets), et 300 mEq de sodium par jour (10 sujets). Les résul-
tats suivants ont été obtenus (moyenne SEM): (1) L'activité
refine plasmatique (PRA) (ng/ml/hr) dans Ia période A (1,13
0.97) était supprimée (P < 0,001) par rapport a Ia période B (5,45
0,83) et comparable aux valeurs observées chez les enfants
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charges en sel (1,91 0,27). (2) L'aldostérone plasmatique
(PAid0) (pg/mi) suivait la méme evolution (période A, 81,6 23,3;
période B, 289,3 52,1; contrôles a 300 mEq de sodium par
jour, 68,8 9,6), de méme que l'aldostérone urinaire (UAIdO) (p.g/
jour) (période A, 4,07 1,01; période B, 30,16 7,06; contrôles
a 150 mEq de sodium, par jour, 27,87 7,01). (3) Ii n'y avait pas
de difference entre Ia période B et les contrôles en restriction de
sodium. (4) II n'y avait pas de difference dans Ia clearance de
l'aldostérone, 1'ACTH plasmatique, Ic potassium sérique, et un-
naire chez les malades et les contrôles. (5) Des correlations ont
été observées entre PRA et PAId0 (r = 0,78; P < 0,001) ou UAId,, (r
0,82; P < 0,001) semblables a celles des contrôles. (6) La
sévérité de l'hypertension était corrélée a Ia retention liquid-
ienne (r = 0,741; P < 0,001). (7) La retention liquidienne était
corrélée a la suppression de PRA (exprimée en pourcentage de
sa valeur pendant Ia période B), la relation suggérant que 80% de
suppression sont réalisés rapidement par un gain de poids de 5 a
6%. II est conclu que, chez nos malades, le système rénine-al-
dostérone paralt fonctionner de facon physiologique. Le degré
de suppression et Ia relation interne sont comparables a ce qui
est observe au cours de Ia réponse normale.
The acute nephritic syndrome is a clinical entity
characterized, in its typical form, by the sudden de-
velopment of edema, hypertension, hematuria, and
diminished urinary output [1]. The best recognized
etiology of this syndrome is acute poststreptococcal
glomerulonephritis [2]. Several studies have ana-
lyzed the cardiovascular aspects of the disease [3—
6], and the concensus of these investigations is that
overexpansion of the vascular compartment is re-
sponsible for the hemodynamic characteristics of
these patients [7]. Considerable research has been
devoted to the clarification of the events that lead to
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sodium and fluid retention. Careful experimental
studies [8-10] have focused on the decreased GFR
and the compensatory mechanisms that are brought
into play.
In contrast, only limited information is available
on the role of humoral factors in the patho-
physiology of the nephritic syndrome. Plasma renin
determinations have been reported by Birkenhager
et al [11] to be subnormal in one patient and normal
in another. Powell et al [12] found low plasma renin
activity in 10 children with azotemic acute glomeru-
lonephritis. The suggestion was made in the first of
these studies [11] that inappropriate renin secretion
was a feature of acute glomerulonephritis. Both of
these studies gave, however, little information in
control children that would permit analysis of the
appropriateness of renin suppression. To our
knowledge, there are no reports on aldosterone
measurements in this syndrome.
The purpose of this paper is to analyze the renin-
aldosterone system in the acute nephritic syndrome
in relation to other clinical and laboratory parame-
ters. Our studies were performed in patients with
poststreptococcal glomerulonephritis because this
disease is very common in our population [2, 13],
and because the good prognosis associated with this
etiology permits restudy of the patients after recov-
ery in a relatively short period of time. Comparative
values can then be obtained for each individual pa-
tient and relationships established with control
groups subject to sodium restriction and sodium
loading.
Methods
Patients. Thirteen patients (6 females and 7
males) with acute nephritic syndrome were the sub-
ject of these studies. Their ages ranged between 4
and 14 years. The poststreptococcal etiology of the
nephritis was established by serologic evidence of
antistreptococcal activity and, in addition, group A
beta hemolytic streptococcus was isolated from the
skin or throat in 4 patients (patients 1, 3, 5, and 9).
The site of antecedent infection was the skin in 4
patients, upper respiratory in 7 patients, both skin
and upper respiratory in 1 patient, and the site of
infection was unknown in 1 patient. All patients had
typical findings of acute nephritic syndrome, and
all, except patient 4, also had gross hematuria. Mi-
croscopic hematuria with red cell casts was demon-
strated in all the patients. Routine laboratory work-
up ruled out any systemic disease, and the sub-
sequent outpatient course confirmed the self-limited
nature of the nephritic episode.
Eight patients had skin biopsy, and five of them
had immunohistologic findings compatible with
poststreptococcal glomerulonephritis [14]. Renal
biopsy was performed in 5 patients, and studies by
light, immunofluorescence, and electron microsco-
py methodology were consistent with the post-
streptococcal etiology. In all patients, the diagnosis
was felt to be well documented.
The patients were studied twice. The first study
(period A) was made during the acute nephritic syn-
drome, within 48 hours after the patient's admission
to the hospital, when the patient had received no
medication except for penicillin (1,200,000 U, i.m.),
which was given after the cultures were obtained.
The second study (period B), was made after the
patient's recovery from the acute nephritic episode,
as indicated by the return to normal of the creati-
nine clearance and C3 levels, and by the lack of ede-
ma, hypertension, or gross hematuria. Microscopic
hematuria (more than 4 red blood cells consistently
per high power field) was still present in all cases.
Period B studies were performed between 4 and 6
weeks after the initial admission. Twelve patients
were studied twice as stated, and one patient (pa-
tient 12) refused to have laboratory studies per-
formed after recovery, and consequently, only clin-
ical data for period B is available in this patient.
Because the administration of antihypertensive
or diuretic drugs would alter the parameters under
study, only patients without severe hypertension or
congestive heart failure were selected. Decisions
were made, individually, by the patient's pediatri-
cian and two other staff physicians, as to the possi-
bility of withholding initial active drug therapy. If
subsequent hospital course dictated the need for
antihypertensive medication, the patient was with-
drawn from the study. By definition then, the pa-
tients reported in detail presented a mild to a mod-
erately severe clinical picture. Blood samples, how-
ever, were obtained on admission in 5 additional
patients (ages, 8 to 14 years) with severe hyper-
tension (diastolic blood pressure ranging from 115
to 120 mm Hg) in whom antihypertensive and diu-
retic (furosemide) medication could not be withheld
and would not be included in the study protocol.
These data were not used for critical analysis but to
determine whether severely affected children had
renin and aldosterone levels different from the rest
of the patients in the study.
Informed consent was obtained from the patient
or the parents in every case.
During both periods of study, the patients were
on a low-salt diet (10 mEq of sodium per day) with
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balanced composition, calculated to provide ap-
proximate caloric, protein, carbohydrate, and lipid
daily requirements. This low-sodium diet was insti-
tuted on admission as part of the treatment of the
acute nephritic syndrome, and was continued even
after the disappearance of the symptoms because it
is our routine to maintain this diet for 1 month after
clinical recovery. In addition, it was felt that the re-
nin-aldosterone system could be best evaluated by
analyzing the range imposed by overexpansion on
one side (period A), and by sodium restriction on
the other (period B). Compliance with the diet was
supervised during period A and at least for 3 days
prior to the studies of period B.
The studies performed in both these periods in-
cluded a supervised 24-hour urine collection (stor-
ing the urine at 40 C), and blood samples taken with
the patient in the recumbent position, at 7 A.M. be-
fore arising, and at midmorning (approximately
11 A.M.) in the standing position after 2 to 3 hours of
ambulation. A record of the arterial blood pressure
(recumbent, before blood sampling) was made by
two observers to a 5 mm Hg precision. The weight
was determined before breakfast with a discrimina-
tion of 0.1 kg.
Control subjects. Apparently healthy, age- and
sex-matched children were used as control sub-
jects. They had normal blood pressures for their re-
spective age groups and normal renal functions as
estimated by urinary sediment analysis, negative
24-hour proteinuria, and 24-hour creatinine clear-
ance in the normal range. Control subjects included
a total of 38 children, as follows:first, 18 children
(half of each sex) ranging in age from 4 to 16 years,
who were admitted to the Hospital Universitario or
to the Cilnica San Rafael for elective hernia repair
or orthopedic procedures for polio sequelae. All
were ambulatory and in apparently normal nutri-
tional status. They were placed on a diet containing
150 mEq of sodium per day (3 to 6 mEq of sodium
per kg of body wt per day) for 3 days prior to the
studies. Children in this group had 24-hour urine
collections, recumbent and upright plasma renin ac-
tivity (PRA) and plasma aldosterone (PA1dO) mea-
surements, and urinary studies as detailed for the
patients with acute nephritic syndrome.
Second, 10 children studied after being on a diet
containing 10 mEq of sodium per day (0.2 to 0.5
mEq/kg/day) similar to that of the patients, for 3
days prior to the studies. Third, 10 additional chil-
dren that were placed on a regular diet containing
150 mEq of sodium per day, but received additional
sodium supplements to reach a daily ingestion of
300 mEq of sodium per day (10 to 15 mEq/kg/day).
The children on the low-salt (10 mEq/day) and high-
salt (300 mEq/day) diets were divided equally by
sex and age (range, 6 to 14 years). They were not
hospitalized but closely supervised, and the daily
urinary sodium determinations confirmed adher-
ence to the diets (Table 3). Nonhospitalized control
children did not have supine blood samples taken,
and they did not have urinary aldosterone determi-
nations made.
Laboratory determinations. Twenty-four-hour
urine samples were measured, and aliquots were
used for determinations of creatinine, sodium, and
potassium. Further aliquots were kept at _7Ø0 C for
determinations, at a later date, of urinary aldoste-
rone. Serum samples were used for determinations
of creatinine and electrolytes. Plasma samples were
used for measurement of PRA (collected in EDTA
tubes), PA1dO, and ACTH. Samples for hormonal de-
terminations were collected in chilled syringes, trans-
ported in ice, immediately centrifuged (x l000g)
at 40 C for 20 mm (Sorvall 5RC Centrifuge, Dupont
Instruments Medical Division, Newtown, Connect-
icut), and the plasma was separated and kept at
—70° C until determinations were carried out in
duplicate.
Determinations of PRA were performed accord-
ing to Haber et al [15] as reported previously [16],
with commercially available radioimmunokits
(RENK, Sorin Biomedica, Saluggia, Vercelli, Ita-
ly). Intra-assay repeatibility in three samples of
1.49, 2.05, and 4.92 ng/ml/hr (ten determinations
each) had a variation coefficient of 5.3%, 6.1%, and
5.6%, respectively. The recovery experiments gave
results of 83.5 5,0%. The sensitivity was 0.08
0.03 ng/ml/hr. Inter-assay variation coefficient was
8.6%.
Plasma aldosterone was measured by the method
of Malvano et a! [17] with radioiodinated aldoste-
rone (ALDOCTK- 125, Sorin Biomedica, Saluggia,
Vercelli, Italy). The variation coefficient in samples
of 53, 173, and 328 pg/ml was 11.0%, 7%, and 9%,
respectively. Recovery experiments gave results of
80.2 6%. Urinary aldosterone (UAIdO) was deter-
mined with tritiated aldosterone (ALDOK, Sorin
Biomedica, Saluggia, Vercelli, Italy) by the method
of Malvano et al [18]. The variability coefficient in
three 24-hour urine samples of 5.1, 15.0, and 36.0
pg/day was 15.2%, 9.0%, and 7.0%, respectively.
Plasma ACTH was measured by the method of Ben-
son and Yalow [19] with commercial radioimmuno-
kits (ACTHK, Sorin Biomedica, Saluggia, Vercelli,
Italy).
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Calculations. Fractional sodium excretion was
calculated as the percent of filtered sodium:
(UNa/PNa) x l00I(tJcr/Pcr)
The amount of fluid retention during the acute
nephritic stage was estimated as the difference in
body weight (BW) in the two periods of the study
(period ABW — period BBW), and in some analyses is
expressed as percent increase over the dry weight
of period B: LBW x 100/period BBW.
The severity of hypertension was estimated as
the difference between the mean blood pressure
(diastolic + [systolic — diastolic]/3 = BP) in the pe-
riods of study: period ABP— period B= z BP.
Creatinine clearances were calculated for 1.73 m2
of surface area. Statistical calculations used were
standard Student's t analysis and two-variable cor-
relation.
Results
General data. Table 1 shows the pertinent fea-
tures in the patients. The proteinuria during period
A ranged from 200 mg/day (patients 4 and 6) to 1100
mg/day (patient 10). Fibrinogen degradation prod-
ucts in the urine ranged from 1.25 to 5 p.g/ml in the
acute phase, and were still detectable in patients 5
(5.0 j.g/ml) and 7 (2.5 jg/ml) in period B of the
study. Serum C3 levels were below 100 mg/dl in all
but one patient in period A and had returned to nor-
mal in period B in every case.
As can be calculated from Table 1, the mean
blood pressure increment during the acute nephritic
syndrome was 27.8 (SD) 11.36mm Hg. The mean
fluid retention was 1.4 kg, which expressed as per-
cent increment of dry weight of period B cone-
sponds to values of 9.63 (SD) 17.44%.
Serum creatinine and serum and urinary elec-
trolytes (not shown in Table 1) are as follows (mean
SD): Serum creatinine (mg/dl) was 0.97 0.25 for
period A and 0.72 0.11 for period B (P < 0.001).
Serum sodium (mEq/liter) was 137.7 4.04 for peri-
od A and 140.2 2.52 for period B. Serum potas-
sium (mEq/liter) was 4.7 0.66 for period A and 4.3
0.33 for period B. Urinary sodium excretion
(mEq/day) was 25.5 19.18 for period A and 13.3
8.69 for period B. Urinary potassium excretion
(mEq/day) was 9.13 5.3 for period A and 17.85
12.7 for period B.
Renin-aldosterone studies. Table 2 indicates the
results obtained in both periods of study for PRA,
PAid0 (recumbent and postambulatory), UAIdO and
PACTH. Mean values may be compared with those of
Table 1. Features of the acute nephritic syndromea
.Patient no.
(age, sex) Presenting symptoms
Blood pressure
mmHg
A B
Body weight
kg
A B
U/Pa.
A B
FENa
%
A B
Ccrb
mi/mm
A B
1 ( 6, M) Facial and leg edema, 120/90 90/50 18.7 17.6 48.6 79.0 0.71 0.10 65.4 80.0
dark urine
2(l4,M) Darkurine,facialedema 130/90 110/60 50.8 50.0 36.5 87.0 0.26 0.06 28.6 84.1
3(13,M) Facialandlegedema, 150/100 110/80 30.3 29.8 75.1 62.9 0.83 0.05 66.8 98.6
dark urine
4(10,M) Generalizededema,dyspnea 170/90 90/60 39.1 33.7 192.6 217.4 0.28 0.06 50.1 93.1
5 ( 5, M) Facial and leg edema, 120/80 90/60 17.8 17.4 137.5 50.3 0.06 0.05 85.9 107.7
dark urine
6( 4,F) Generalized edema, 120/85 90/50 15.0 14.2 68.0 117.0 0.81 0.29 40.5 82.8
dark urine
7( 4,M) Facial edema, oliguria, 100/60 70/40 18.0 17.7 83.9 322.5 0.66 0.23 53.5 192.1
dark urine
8( 9,F) Leg edema, dark urine 100/60 70/40 29.3 28.0 50.3 71.4 0.50 0.20 46.5 91.2
9(12, F) Facial edema, dark urine 130/80 90/60 29.9 27.5 56.3 198.0 0.73 0.05 30.1 143.9
l0( 4,F) Generalized edema, 120/80 90/40 15.8 14.7 84.0 50.3 0.55 0.16 39.8 175.5
dark urine
11 ( 9, F) Leg and facial edema, 90/60 80/50 26.0 25.3 26.1 85.1 0.23 0.09 29.3 197.9
dark urine
12( 7,F) Facialedema,darkurine 100/80 90/40 25.8 25.3 75.2 ND 0.83 ND 62.8 ND
13(13,F) Generalizededema, 125/85 100/70 46.6 44.5 27.8 148.5 0.52 0.02 11.5 130.3
dark urine
Mean 27.9 26.5 73.9 124.1 0.53 0.11 46.9 123.1
SD 11.6 11.0
A and B refer to periods A and B of the study (see text). The differences in mean values in A and B are significant (P < 0.01 or lower)
for the weight loss, fractional sodium excretion (FENa) and creatinine clearance (Ccr). ND denotes not done.
Creatinine clearance has been corrected for 1.73 m2 of surface area.
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Table 2. Renin-aldosterone studiesa
•Patient
no.
Recumbent PRA
ng/mi/hr
A B
Recumbent PAid0
pg/mi
A B
Upright PRA
ng/ml/hr
A B
Upright PAIdO
pg/mi
A B
UAIdO
p.g/day
-
A B
PACTH
pg/mi
A B
1
2
3
4
5
6
7
8
9
10
11
12
13
Mean
1.20 8.90
0.10 6.59
0.66 2.73
ND 3.60
0.99 0.46
ND 12.59
2.33 12.60
2.33 11.80
0.76 3.66
0.93 6.59
4.39 9.86
0.07 ND
0.73 8.33
1.31 7.31
ND 60.0
10.0 192.5
22.0 147.5
ND 367.5
86.5 ND
ND 502.5
18.0 402.0
125.0 290.0
ND 147.5
15.0 195.0
ND 202.5
5.0 ND
35.0 290.0
39.5 254.2
1.33 9.50
ND 7.20
0.86 1.86
0.13 5.90
1.53 2.19
1.06 4.62
ND 4.66
2.35 11.20
0.33 3.19
0.63 7.53
3.26 3.99
0.07 ND
0.87 3.62
1.13 5.45
56.0 70.0
ND 300.0
85.0 105.0
45.0 600.0
185.0 185.0
95.0 250.0
ND 235.0
264.0 380.0
15.0 47.0
20.0 285.0
62.5 540.0
20.0 ND
50.0 475.0
81.6 289.3
5.1 15.9
3.4 78.7
3.8 3.8
1.2 32.0
1.9 0.9
1.0 16.8
1.1 21.0
11.8 30.8
1.6 48.0
1.1 9.7
11.2 36.3
5.9 ND
3.8 68.0
4.07 30.16
ND 13.0
20.0 70.0
5.0 5.0
10.0 10.0
57.0 ND
ND ND
5.0 ND
5.0 ND
30.0 ND
22.0 30.0
32.0 30.0
5.0 ND
5.0 5.0
17.8 23.2
A and B refer to periods A and B of the study, respectively (see text). Mean values of plasma aldosterone (PAIdO), urinary aldosterone
(UAIdO), plasma renin activity (PRA) in period A are significantly different (P < 0.001) from the corresponding values in period B.
Recumbent determinations and postambulatory (upright) determinations of PRA and PAIdO were not statistically different (paired t test) in
either period of study.
Table 3. Summary of data of control subjects°
Group 1
(lOmEqNa)
Group 2
(l5OmEqNa)
Group 3
(300mEqNa)
Creatinineclearance,ml/min 93.8 3.68
(N = 10)
118.9 11.69
(N = 17)
108.9 5.70
(N = 10)
Urinary sodium, mEq/day 14.8 2.20
(N= 10)
155.7 15.5
(N= 17)
324.4 19.8
(N= 10)
Urinary aldosterone,
pg/day 27.87 7.01
(N= 15)
pg/kg/day 0.79 0.40
(N= 15)
Plasmareninactivity,ng/mi/hr 8.53 0.88(N = 10)
5.36 0.68
(N = 16)
1.91 0.27
(N = 10)
Plasmaaldosterone,pg/mi 273.5 32.8
(N=10)
117.0 13.2
(N=13)
68.8 9.6
(N=10)
Plasma ACTH,pg/mi 23.6 12.1
(N= 10)
Groups 1-3 refer to three groups of children on diets with the noted sodium content. Creatinine clearance values are expressed per
1.73 m2 surface area. Plasma renin and aldosterone values correspond to postambulatory determinations.
control children on diets of 10, 150, and 300 mEq of
sodium per day, summarized in Table 3.
The mean PRA and PAid0 levels in the patients
during the acute stage are not significantly different
from the levels obtained in controls on a high so-
dium diet, and the mean values of PRA and PAIdO in
period B studies are not statistically different from
the values of control children on a similarly restrict-
ed sodium diet (group 1 in Table 3). Plasma renin
activity and PAIdO at the time of period A were signif-
icantly lower than the corresponding value at the
time of period B. These findings are shown in Fig. 1,
which relates the urinary sodium excretion with
PRA levels in patients and control subjects. There
was a correlation between PRA and PA1dO in period
A upright values (r = 0.89, P < 0.00 1) as well as for
all values in postambulatory (r = 0.52, P < 0.02) or
recumbent (r = 0.78, P < 0.001) samples in the pa-
tients. The latter relationship is shown in Fig. 2, in
association with data from control children. The 5
patients with severe hypertension that could not be
included in the study protocol had a PRA mean lev-
el of 0.622 (SD) 0.622 ng/ml/hr, and their mean
PAIdo level was 62.6 (SD) 75.6 pg/ml. The individ-
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Fig. 1. Upright plasma renin activity and urinary sodium excre-
tion. Control children (0) on sodium diets of 10, 150, and 300
mEqlday (each point corresponds to one patient, r = 0.71, P <
0.001) are shown in comparison with patients in the acute ne-
phritic syndrome (period A, •), and after recovery on a low-
sodium diet (period B, A).
ual values of these severely hypertensive children
are included in Fig. 2, and they are somewhat
lower, but not significantly so, than the values of
period A.
Mean urinary aldosterone levels in the patients
were significantly lower in period A (P < 0.001)
and there was no significant difference between the
levels of patients in period B and that of controls on
a diet of 150 mEq of sodium per day. The variability
of urinary aldosterone excretion (Table 2) probably
explains this lack of statistical significance. The
same results were obtained when daily aldosterone
excretion was related to body weight: period A was
0.18 0.14, and period B was 1.03 0.54 g/kg/
day. A significant correlation existed between UA1dO
and PRA. This correlation was demonstrated with
either upright (r = 0.62, P < 0.01) or recumbent (r =
0.82, P < 0.001) PRA determinations in both peri-
ods of study.
Calculated aldosterone clearances gave mean val-
ues of 161.7 85.8 for period A, 107.0 21.0 for
period B, 144.6 28.7 for control children. These
figures are not statistically different from each oth-
er.
The postural changes in PRA and PAIdOwere mea-
sured in control children on a diet of 150 mEq of
sodium per day. In them, the mean difference (up-
right — supine) for PRA was 2.27 0.69 ng/ml/hr (P
<0.01), and for PAid0 it was 33.8 16.8 pg/ml (P <
0.02). But, in the patients, the postural changes
could not be detected. In fact, higher values were
observed in recumbency in several instances (Table
2).
500
475
450
425
400
375
350
325
0, 300
275
250'0
225'
200
175
150
125
100
75
50
25
No correlation could be found between the con-
centrations of serum or urinary potassium, and
plasma or urinary aldosterone in the periods of
study.
The severity of hypertension (zBP) correlated
positively with the fluid retention (BW x 100/Peri-
od BBW) in our patients (r = 0.741, P < 0.01).
The relationship between fluid retention (again
expressed as indicated) and the relative suppression
of PRA (expressed as percent decrease in period A
with respect to period B) is shown in Fig. 3. It is
apparent that 80% suppression of PRA is achieved
with fluid retention equivalent to 5 to 6% of body
weight. Fluid retention two times that magnitude
(about 10% of body weight) is required to suppress
an additional 10% of PRA.
Discussion
The patients under study had the classic features
of the acute nephritic syndrome, and they were din-
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Fig. 2. Plasma renin activity and plasma aldosterone. Control
children on a sodium diet of 10 (0), 150 (0), and 300 (A) mEq/
day are compared with patients in the acute nephritic syndrome
(period A), and after recovery with a low-sodium diet (period B)(r = 0.78, P < 0.001). Patients with severe hypertension (see
text) are also shown.
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ically recovered by the time of the second study.
The decreased GFR and other functional patterns of
the nephritic syndrome have been recognized for
some time [20, 21]. It has recently been indicated
that in acute renal failure due to acute glomerulone-
phritis, as in prerenal conditions, the fractional so-
dium excretion is less than 1%, the U/P creatinine
ratio is more than 40, and the renal failure index
(urinary sodium divided by urinary/plasma creati-
nine [22]), is less than 1 [23]. Fractional sodium ex-
cretion during period A was very close to that re-
ported by Miller et al [23]. Renal failure index in our
patients (0.75 0.36) is in the range reported by
others [23] and so are the urine-to-plasma creatinine
ratios [23, 24].
The possibility to restudy the patients after re-
covery in sodium restriction permitted evaluation of
the renin-aldosterone system over a wide range,
which allowed comparison with renin-stimulated
and renin-suppressed control children. The correla-
tions that were found strongly suggest that the inter-
nal relationship of the renin-aldosterone system is
not different from that present in normal children
with varying sodium intakes. Possible influences on
aldosterone by the levels of potassium and ACTH
could not be detected.
The relation between fluid retention and hyper-
tension is also suggested by our data. Hypertension
occurs in about 90% of our patients with acute post-
streptococcal glomerulonephritis [25]. Table 1
shows that 7 patients had a significant decrease in
blood pressure despite a weight loss of less than 1
kg. This could be taken to indicate the existence of
two populations of patients. But, when the decrease
in BP is related to the decrease in weight expressed
in percent terms (see Methods), the relationship
found was significant to the 1% level (r = 0.741),
which makes the possibility of a double population
unlikely. This correlation is consistent with the
finding of Powell et al [12], who reported a relation-
ship between diastolic blood pressure and percent
weight loss in glomerulonephritis.
Previous reports of supine PRA determinations in
acute glomerulonephritis were in the range of 0.03
to 0.04 ng/ml/hr [12]. Our own values are higher
(Table 2). This could be due to variation in the re-
spective laboratories, because Powell et al [12] re-
port a range of 0.6 to 2.3 ng/ml/hr in children on a
salt-free diet, which is almost comparable to our
own supine values for control children on a regular
diet (see below).
Van Acker et al [26] published mean supine PRA
and PA1UO values of 2.2 ng/ml/hr and 95 pg/ml, re-
spectively, in healthy children on a dietary sodium
intake of I to 4 mEq/kg/day (infants in this study
had lower sodium intakes). These figures are not
too different from our mean recumbent determina-
tions in children with comparable sodium intake
(150 mEq/day, or 3 to 6 mEqfkg/day): PRA, 2.4 ng/
ml/hr; PAIdO, 75.5 pg/ml (data not shown).
In strict sense, the appropriateness of the renin-
aldosterone suppression in the patients should be
best judged in relation to controls matched for renal
failure and hypertension. Such controls are, in prac-
tical terms, impossible to obtain. Some consid-
erations can be made, however, with respect to the
normal individual. Pratt and Luft [27] observed in
adults, that the levels of PRA and PAIdO reached un-
detectable values with diets providing 800 mEq of
sodium per day or more, and higher sodium intake
failed to achieve further suppression of aldosterone
secretory rates. Our control children with a 300-
mEq sodium per day intake had a mean weight in-
crease of 0.62 0.34 kg at day 3 of the diet. This
value is lower, but not statistically different than the
weight increase during the acute nephritic syn-
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Fig. 3. Fluid retention and suppression of plasma renin activily.
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dium-restricted state in period B. Each point corresponds to one
patient.
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drome in our patients (Table 1). Correspondingly,
the mean PRA in patients in period A was lower,
but not significantly so, than the value in control
children on a high sodium intake (1.13 vs. 1.91 ng/
ml/hr), and this may be due to the restricted number
of patients in the study, because the type II (beta)
error of accepting the null hypothesis is 2 1.2%. The
analysis of the patients relating the percent weight
increase with percent suppression of PRA suggests
that the relationship is given by a curve with a slope
that tends to level at about 5 to 6% weight gain and
85% suppression of PRA (Fig. 3). Calculations done
on the mean values reported in normal adults by
Pratt and Luft [27] (individual values not given) sug-
gest a similar pattern in their subjects.
Recently, Meltzer et al [28] have shown that pa-
tients with the nephrotic syndrome may present
with high or with low PRA and PAIdO, and White and
Schambelan [29] found hyperreninemia in necrotiz-
ing renal vasculitis due to hepatitis B surface anti-
gen. In our patients with poststreptococcal neph-
ntis, we did not find evidence of increased renin ac-
tivity, and the data suggest that the renin-
aldosterone axis does not have a pathogenic role in
this clinical situation. Instead, our results indicate
that the suppression observed is comparable to the
physiologic response to sodium loading. It should
be emphasized, however, that our studies concern
patients with moderate hypertension because the
observations in patients with severe hypertension
are too limited to allow definite conclusions.
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